Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zigelman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|July 1, 1989
Using an organizational development strategy to improve residency trainingH Leider, R Zigelman, F Burg
Clinical & Experimental Metastasis|May 1, 1996
Muscle cells produce a low molecular weight factor with anti-cancer activityM Djaldetti, B Sredni, R Zigelman, et al.
Human Antibodies and Hybridomas|January 1, 1996
Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo)O Merimsky, Y Shoenfeld, E Baharav, et al.
The Journal of Clinical Investigation|April 1, 1993
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3P Fishman, E Falach-Vaknine, R Zigelman, et al.
Clinical and Experimental Immunology|July 1, 1996
Tyrosinase as an autoantigen in patients with vitiligoE Baharav, O Merimski, Y Shoenfeld, et al.
Journal of Reproductive Immunology|August 1, 1992
Interleukin-3-like activity levels in pregnant women: possible modulation by progesteroneP Fishman, Y Shoenfeld, J Hart, et al.
International Archives of Allergy and Immunology|January 1, 1993
Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary dataP Fishman, M Kamashta, M Ehrenfeld, et al.
Cancer|October 15, 1993
Vitiligo autoantibodies are effective against melanomaP Fishman, E Azizi, Y Shoenfeld, et al.
Arthritis and Rheumatism|October 1, 1995
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitisY Tomer, B Gilburd, M Blank, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Academic Medicine : Journal of the Association of American Medical Colleges|July 1, 1989
Using an organizational development strategy to improve residency trainingH Leider, R Zigelman, F Burg
Clinical & Experimental Metastasis|May 1, 1996
Muscle cells produce a low molecular weight factor with anti-cancer activityM Djaldetti, B Sredni, R Zigelman, et al.
Human Antibodies and Hybridomas|January 1, 1996
Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo)O Merimsky, Y Shoenfeld, E Baharav, et al.
The Journal of Clinical Investigation|April 1, 1993
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3P Fishman, E Falach-Vaknine, R Zigelman, et al.
Clinical and Experimental Immunology|July 1, 1996
Tyrosinase as an autoantigen in patients with vitiligoE Baharav, O Merimski, Y Shoenfeld, et al.
Journal of Reproductive Immunology|August 1, 1992
Interleukin-3-like activity levels in pregnant women: possible modulation by progesteroneP Fishman, Y Shoenfeld, J Hart, et al.
International Archives of Allergy and Immunology|January 1, 1993
Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary dataP Fishman, M Kamashta, M Ehrenfeld, et al.
Cancer|October 15, 1993
Vitiligo autoantibodies are effective against melanomaP Fishman, E Azizi, Y Shoenfeld, et al.
Arthritis and Rheumatism|October 1, 1995
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitisY Tomer, B Gilburd, M Blank, et al.
Pageof 1